Benchmark Holdings is a biotechnology company specializing in aquaculture products and solutions. The company focuses on enhancing aquaculture productivity and sustainability through its three main divisions: genetics, early-stage nutrition, and health. In genetics, Benchmark's strategy centers on continuous genetic improvement in growth and disease resistance for salmon. The nutrition division, INVE Aquaculture, provides specialized nutrition for early stages of shrimp and marine fish production. The health division develops treatments for sea lice challenges in salmon farming. In 2023, Benchmark reported a 7% increase in revenue and a 15% rise in adjusted EBITDA, with operational cash conversion improving from 35% to 58%. The company's genetics operations are crucial for supplying bio-secure salmon eggs to producers year-round. In October 2023, Benchmark was granted two new salmon broodstock licenses by the Directory of Fisheries in Norway, totaling 780 tonnes, which more than doubled the volume of its current licenses. This expansion aims to increase the security of supply of bio-secure, high-quality eggs with high-performing genetic traits for its customers.
Key customers and partnerships
INVE Aquaculture, a part of Benchmark Holdings since 2015, actively participates in leading aquaculture events worldwide. The company is a founding member of important organizations in the field, including the World Aquaculture Society, the Global Aquaculture Alliance, and the European Aquaculture Technology and Innovation Platform (EATiP). Through these partnerships, Benchmark aims to set new standards for success in rearing aquaculture species and shape the future of the industry in collaboration with the market.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.